Century Link Investment Management CO Bristol Myers Squibb CO Transaction History

Century Link Investment Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 09, 2020	SELL	$54.82 - $64.09 $443,274 - $518,231	-8,086 Closed	0 $0
Q1 2020 Apr 15, 2020	BUY	$46.4 - $67.43 $375,190 - $545,238	8,086 New	8,086 $451,000
Q4 2017 Jan 08, 2018	SELL	$59.94 - $65.35 $799,180 - $871,311	-13,333 Closed	0 $0
Q3 2017 Oct 06, 2017	BUY	$55.23 - $63.74 $736,381 - $849,845	13,333	13,333 $850,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Century Link Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Century Link Investment Management CO with notifications on news.